Neumora Therapeutics NMRA
NASDAQ NMRA
$0.42 -0.05 (-10.54%)
At close: Oct 21, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Price to Sales (2023 - 2026)

Updated

Analysis

Neumora Therapeutics (NMRA) Price to Sales (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Neumora Therapeutics 78.88 Mn -539.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.59
Mar 31, 2026 55.58
Dec 31, 2025 37.38
Sep 30, 2025 27.40
Jun 30, 2025 8.68
Mar 31, 2025 9.72
Dec 31, 2024 85.99
Sep 30, 2024 99.31
Jun 30, 2024 74.48
Mar 31, 2024 113.02
Dec 31, 2023 66.74
API Access

Neumora Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NMRA&period=max&api_key=YOUR_API_KEY